Mirae Asset Global Investments Co., Ltd. Caribou Biosciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,268 shares of CRBU stock, worth $9,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,268
Previous 2,696
21.22%
Holding current value
$9,085
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRBU
# of Institutions
140Shares Held
52.6MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$12.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$11.6 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$11.4 Million0.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.34MShares$6.52 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $169M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...